Table 3.
Milestones for treating CML expressed as BCR-ABL1
IS
per LeukemiaNet
44
Month
.
Optimal
.
Warning
.
Failure
.
3
≤10%
>10%
>10% if confirmed
6
≤1%
>1%-10%
>10%
12
≤0.1%
>0.1%-1%
>1%
Anytime
≤0.1%
>0.1%-1%
>1%
Loss of <0.1%
Month
.
Optimal
.
Warning
.
Failure
.
3
≤10%
>10%
>10% if confirmed
6
≤1%
>1%-10%
>10%
12
≤0.1%
>0.1%-1%
>1%
Anytime
≤0.1%
>0.1%-1%
>1%
Loss of <0.1%
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal